NEW YORK, April 29, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of cellular therapies for neurodegenerative diseases, in collaboration with leading ALS research ...
--BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, in collaboration with leading ALS research centers, today announced the acceptance of new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback